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Abstract
H9N2 subtype avian influenza viruses (AIVs) have shown expanded host range and can infect mammals, such as humans
and swine. To date the mechanisms of mammalian adaptation and interspecies transmission of H9N2 AIVs remain
poorly understood. To explore the molecular basis determining mammalian adaptation of H9N2 AIVs, we compared two
avian field H9N2 isolates in a mouse model: one (A/chicken/Guangdong/TS/2004, TS) is nonpathogenic, another one (A/
chicken/Guangdong/V/2008, V) is lethal with efficient replication in mouse brains. In order to determine the basis of the
differences in pathogenicity and brain tropism between these two viruses, recombinants with a single gene from the TS
(or V) virus in the background of the V (or TS) virus were generated using reverse genetics and evaluated in a mouse
model. The results showed that the PB2 gene is the major factor determining the virulence in the mouse model
although other genes also have variable impacts on virus replication and pathogenicity. Further studies using PB2
chimeric viruses and mutated viruses with a single amino acid substitution at position 627 [glutamic acid (E) to lysine,
(K)] in PB2 revealed that PB2 627K is critical for pathogenicity and viral replication of H9N2 viruses in mouse brains. All
together, these results indicate that the PB2 gene and especially position 627 determine virus replication and
pathogenicity in mice. This study provides insights into the molecular basis of mammalian adaptation and interspecies
transmission of H9N2 AIVs.
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Introduction
Since the first H9N2 subtype avian influenza virus (AIV) was
isolated from turkeys in 1966 in the U.S. [1], this subtype of
viruses has been circulating in birds worldwide. Although H9N2
viruses are often found in shorebirds and wild ducks in North
America [2], there is no evidence of a permanent lineage of these
viruses in land-based poultry [3]. In Asia, H9N2 subtype of AIVs
has become endemic in domestic poultry in many countries
[4,5,6,7,8,9]. Noticably, H9N2 viruses have transmitted from
land-based chickens to pigs [10,11,12,13,14,15]. Also, H9N2
viruses have been reported to infect humans and caused mild
respiratory disease [12,16,17]. Further evidence of its mammalian
host range is that some H9N2 strains replicate efficiently in mice
and are able to kill mice without prior adaptation [5,18]. All these
facts indicate that H9N2 AIVs have expanded their host range and
are able to infect different mammalian hosts including humans.
Although infections of humans with H5, H7 and H9 AIVs have
been documented, the molecular mechanism for adaptation of
AIVs in mammalian hosts remains poorly understood. The surface
protein hemagglutinin (HA), which is responsible for binding of
the virus to cellular receptors, is a major determinant in the host
range of influenza A viruses. The HAs of AIVs preferentially bind
to a2,3 sialic acid receptors, whereas the HAs from human
influenza viruses preferentially bind to a2,6 sialic acid receptors
[19]. Normally, the receptor binding site of the H9N2 HA similar
to other AIVs’ HAs contains 226Q (glutamine, Q) and 228G
(Glycine, G); an increasing number of currently circulating H9N2
isolates carry an leucine (L) at position 226 in the receptor binding
site, a position which has been shown to be critical for influenza
replication efficacy in human airway epithelial cells [20]. The
polymerase PB2 gene is also a major factor of host range for
human influenza viruses and highly pathogenic H5N1 AIVs; a
single-amino-acid substitution at position 627 of the PB2 protein
from glutamic acid (E) to lysine (K) is responsible for virulence in
mammalian species [21,22,23]. Previous adaption studies showed
that mouse adapted H9N2 viruses contain PB2 627K which is
associated with efficient replication and virulence of H9N2 AIV in
mice [3,24].
In this study, we characterized two H9N2 AIVs that were
isolated from chickens, A/chicken/Guangdong/TS/2004 (TS)
and A/chicken/Guangdong/V/2008 (V) in southeastern China.
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differ significantly in virulence and tissue tropism in mice. To
determine the molecular basis for the difference in virulence and
tissue tropism in mice, we generated recombinant and mutated
viruses via reverse genetics and tested them in the mouse model.
Our results showed that the single amino acid substitution at
position 627 of the PB2 protein from E to K contributes to efficient
replication and lethality of H9N2 AIVs in mice.
Materials and Methods
Cells and Viruses
Human embryonic kidney cells (293T) were purchased from the
China Center for Type Culture Collection (CCTCC) and
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum and 1% antibiotics,
and were incubated at 37uCi n5 %C O 2. The H9N2 influenza A
virus A/chicken/Guangdong/TS/2004 (TS) was isolated from the
lung of a dead chicken in a poultry farm with an outbreak of
respiratory disease in Guangdong, China, in 2004. The H9N2
influenza A virus A/chicken/Guangdong/V/2008 (V) was isolat-
ed from rectal swabs of diseased chickens in Guangdong, China, in
2008; the diseased chickens showed sneezing, depression and
diarrhea with a low mortality. Both viruses were amplified in 10-
day-old SPF embryonated eggs and used in this study.
Construction of Plasmids
To establish eight-plasmid reverse genetic systems for the TS
and V viruses, a bidirectional transcription vector (pDL) was used.
The pDL contains human RNA pol I promoter and murine RNA
polymerase I terminator sequences, which are flanked by the RNA
polymerase II promoter of human cytomegalovirus and SV40 late
polyadenylation signal. Two BsmB I restriction sites were utilized
to clone viral full-length cDNA between RNA pol I promoter and
terminator. The viral cDNAs were amplified by RT-PCR with
primers containing BsmB I sites (primers are available upon
request), and then digested with BsmBI, and cloned into the BsmBI
sites of the pDL vector. The resulting plasmids (pDL-V-PB2, -PB1,
-PA, -HA, -NP, -NA, -M and –NS; pDL-TS-PB2, -PB1, -PA, -HA,
-NP, -NA, -M and –NS) were confirmed by sequencing (primers
are available upon request). Mutations were introduced into the
PB2 gene by site-directed mutagenesis Kit (Invitrogen). The
resulting plasmids are pDL-V-PB2-627E and pDL-TS-PB2-627K,
Figure 1. Weight changes, mortality and virus titers of mice inoculated with the TS and V virus. A) Weight changes of mice; B) Mortality
of mice; C) Virus titers of the mouse lungs and brains: four-week-old SPF BALB/c mice (thirty mice/group) were inoculated intranasally with 10
6 EID50
of each virus and three mice were euthanized on each day post infection and organ tissues were collected for virus titration in eggs. Data shown are
the log10 geometric mean EID50/ml 6 SEM; dashed line indicates detection limit of 10
1 EID50/ml.
doi:10.1371/journal.pone.0040118.g001
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tion were prepared by using the Perfectprep Plasmid mini kit
(Eppendorf, Hamburg, Germany).
Generation of Recombinant Viruses Using Reverse
Genetics
An eight plasmid reverse genetic system was used to generate
wild-type and recombinant viruses. A monolayer of 293T cells
with approximately 90% confluence in six-well plates was
transfected with 5 mg of the eight plasmids (0.6 mg/each plasmid)
by using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. Briefly, 5 mg of plasmids and 10 mL
of lipofectamine 2000 were mixed, incubated at room temperature
for 30 min, and then added to the cells. After 6 hours incubation
at 37uC, the mixture was replaced with DMEM containing 2%
fetal bovine serum and 0.2 mg/mL TPCK-treated trypsin. The
supernatant was harvested after 2 days incubation and 100 mLo f
supernatant was injected into an embryonated egg for virus
propagation. The inoculated eggs were incubated for 3 days and
the allantoic supernatant was collected and tested by hemagglu-
tination assay. The rescued viruses were confirmed by sequencing
of the whole viral genome.
Chicken Experiment
To determine the pathogenicity of the two H9N2 viruses, the
Intravenous Pathogenicity Index (IVPI) test was performed
according to the recommendation of the Office International
Des Epizooties (OIE). The chicken experiment was approved by
the Institutional Animal Care and Use Committee at South China
Agricultural University. Twenty-four 6-week-old SPF white
leghorn chickens were randomly allocated into 3 groups (8
chickens/group). Each chicken was intravenously inoculated
through the wing vein with 0.2 mL of inoculum containing 1:10
of virus (original virus HA titer $1024) or 0.2 mL of sterile
phosphate-buffered saline (PBS) in the control group. The birds
were monitored daily for 10 days and scored based on the OIE
recommended scoring system: 0 if normal, 1 if sick, 2 if very sick
and 3 if dead.
Mouse Experiments
Four-week-old female BALB/c mice (Guangdong Experimental
Animal Center, Guanzhou, China) were used in this study. All
mouse experiments were approved by the Institutional Animal
Care and Use Committee at South China Agricultural University.
Mice were intranasally inoculated with 10
6 50% egg infection
doses (EID50) of each virus per mouse in 40 mL sterile PBS or
40 mL sterile PBS in the control group under light anesthesia.
Mice were monitored daily for weight loss and clinical signs. If a
mouse lost body weight over 25% of its pre-infection weight, it was
defined as dead and humanely euthanized immediately; the rest of
the mice were sacrificed at the end of experiment on 10 days post
infection (dpi). The 10% of homogenate of each organ tissue in
PBS was used for virus titration in 10-day-old embryonated
chicken eggs. Virus titers were given in units of log10EID50 per mL
6 standard deviation (SD).
In the first experiment, 90 mice were randomly divided into 3
groups (30 mice/group). Mice were intranasally infected with the
TS or V virus, or PBS as controls. Three mice in each group were
euthanized to investigate viral replication and tissue tropism from
1 to 10 dpi. The tissues collected from each animal included heart,
liver, spleen, lung, kidney, duodenum, rectum and brain.
Histopathological analysis were performed using H & E and
IHC staining (using an in-house anti-HA monoclonal antibody as
the first antibody) on samples collected on 5 dpi.
In subsequent experiments, 11 mice were used in each group.
Three mice in each group were euthanized on 3 and 5 dpi. The
remaining 5 mice were monitored daily for weight loss and
mortality until 10 dpi. During necropsy, lung and brain were
collected for virus titration.
Statistical Analyses
The log10 transformed virus titers were analyzed using
ANOVA, with a P-value #0.05 considered statistically significant
(GraphPad Prism, GraphPad Software, La Jolla, CA). Virological
measures shown to be significantly different by treatment group
were compared pairwise by using the Tukey–Kramer test.
Results
Virulence of TS and V H9N2 Viruses in Chickens and Mice
Chickens inoculated with either TS or V virus did not show any
clinical signs during the experimental period, similar to the control
chickens. The IVPI of both TS and V H9N2 viruses is 0,
indicating they are nonpathogenic for chickens although they were
isolated from diseased or dead chickens. In infected mice, the TS
virus did not induce weight loss and any clinical signs, whereas the
V virus caused severe weight loss and clinical signs including
decreased activity, huddling, hunched posture and ruffled fur
(Figure 1A). The V virus caused 100% mortality in infected mice,
whereas no mice died in the TS virus infected group (Figure 1B).
Both viruses were able to replicate in mouse lungs; however, the V
Table 1. Virus replication in mouse lungs and brains on 3 and
5 days post infection.
Viruses Lung Brain
3 dpi 5 dpi 3 dpi 5 dpi
TS 3.8360.14
a 3.7560.14 ,1
b ,1
r-TS 3.9160.05 3.9760.05 ,1 ,1
TS-VPB2 5.6760.38 5.6760.38 1.1160.14 1.060.43
TS-VPB1 4.0060.29 4.6760.38 ,1 ,1
TS-VPA 4.3360.38 4.3360.50 ,1 ,1
TS-VHA 3.9160.43 4.3360.43 ,1 ,1
TS-VNP 4.6760.50 4.6760.43 ,1 ,1
TS-VNA 4.6760.43 4.6760.43 ,1 ,1
TS-VM 4.1160.29 4.9160.29 ,1 ,1
TS-VNS 3.1160.14 3.1160.29 ,1 ,1
V 5.9760.06 6.0360.06 1.4260.53 1.3560.32
r-V 6.0160.05 6.0760.04 1.3360.66 1.2560.66
V-TSPB2 4.9160.38 4.9160.43 ,1 ,1
V-TSPB1 5.0060.43 5.3360.29 ,1 ,1
V-TSPA 6.0060.43 5.9160.14 ,1 ,1
V-TSHA 6.1160.43 5.3360.50 ,1 ,1
V-TSNP 5.3360.14 5.6760.43 ,1 ,1
V-TSNA 5.6760.29 5.6760.43 ,1 ,1
V-TSM 5.3360.29 5.6760.38 ,1 ,1
V-TSNS 6.0060.38 5.6760.29 ,1 ,1
aNumbers are log10 geometric mean EID50/ml 6 SEM.
bThe detection limit is 10
1 EID50/ml.
doi:10.1371/journal.pone.0040118.t001
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Interestingly, besides the lung the V virus was also detected in
brains of infected mice, but not in other tissues. In contrast, the TS
virus was not found in the brain and other tissues with the
exception of the lungs (Figure 1C). Both the V and TS viruses
induced moderate bronchopneumonia in infected mice. The TS
caused slightly fewer microscopic lung lesions in infected mice on
5 dpi than did the V virus; no significant difference was observed
among the groups inoculated with the V or TS virus (data not
shown). The V virus induced nonsuppurative encephalitis with
proliferation of neuroglial cells in infected mice on 5 dpi, whereas
the TS virus did not. This finding was confirmed by detecting viral
antigens in the brains of mice infected with the V but not the TS
virus using IHC staining (data not shown).
Virulence of Wild-type and Recombinant Viruses in Mice
The eight plasmid reverse genetic system was established for
both the TS and V viruses. Both r-TS and r-V viruses generated
by reverse genetics retained the biological properties of their wild-
type viruses in terms of pathogenicity and tissue tropism in mice as
described above (Table 1, Figure 2).
To determine the genes responsible for differences in virulence
between the TS and V viruses in mice, eight recombinant viruses
containingasinglegenefromtheVvirusinthegeneticbackgroundof
the TS virus (designated TS-VPB2, TS-VPB1, TS-VPA, TS-VHA,
TS-VNA,TS-VNP,TS-VMandTS-VNS)weregeneratedandtheir
replication and virulence was tested in mice (Table 1). Several
recombinant viruses including TS-VPA and TS-VNA caused
transient weight loss (approximately 10%at 7 dpi) and clinical signs
in infected mice, but only the TS-VPB2 caused severe disease with
100%mortality(Figure2A).TherecombinantTS-VPB2virusgrew
toasignificanthighervirustiterinmouselungsthantheparentalr-TS
virus; no significant differences in lung virus titers were observed
among the other 7 recombinant and the parental viruses. Interest-
ingly,onlytheTS-VPB2(3and5 dpi)viruswasalsofoundinmouse
brains similar to the parental V virus (Table 1). These results
indicatedthatPB2fromtheVvirusiscriticalforvirusreplicationand
virulence inmice.
In addition, eight recombinant viruses containing a single gene
from the TS virus in the genetic background of the V virus
(designated V-TSPB2, V-TSPB1, V-TSPA, V-TSHA, V-TSNA,
V-TSNP, V-TSM and V-TSNS) were generated and tested in
mice. When compared to the parental r-V virus, the recombinant
viruses except V-TSPB2 caused obvious weight loss and clinical
signs in infected mice (Figure 2B); the parental r-V was
attenuated due to the introduction of a single gene from the TS
virus although recombinant V-TSPA, V-TSHA, V-TSNS and V-
TSNA viruses still induced mortality in infected mice (Figure 2C).
Figure 2. Weight changes of mice infected with wild-type, parental and recombinants viruses. A) Weight changes of mice inoculated
with the wild-type TS, parental r-TS and recombinant viruses. B) Weight changes of mice inoculated with the wild-type V, parental r-V and
recombinant viruses.
doi:10.1371/journal.pone.0040118.g002
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weight loss and no clinical signs and they gained weight similar to
the control mice (Figure 2B). All recombinant viruses were able
to replicate in mouse lungs, but the recombinant viruses
containing PB2, PB1, NP and M from TS virus replicated to
lower titers when compared to the parental r-V and other
recombinant viruses (Table 1). Noticeably, no virus was found in
mouse brains infected with any of recombinant viruses. These
results indicated that genes from the TS virus affected viral
replication and tissue tropism of recombinant viruses in the genetic
background of the V virus. All above results indicated that PB2
plays a major role for the observed differences in viral replication,
tissue tropism and pathogenicity in mice.
Sequence Comparison of TS and V Viruses
The full genome sequence analysis showed both viruses had
90.7–98.2% identity at the nucleotide level and 93.8–100%
identity at the amino acid level between genes/proteins of the
TS and V viruses (GenBank accession No.: JQ639775–
JQ639790). There were a total of 101 amino acid differences
between these two viruses. In the surface proteins, there were
15 amino acid differences in the HA protein and 29 amino acid
differences in the NA protein between the TS and V viruses
(Table 2). Noticeably, both HAs contain 226Q that has been
demonstrated to bind avian-like influenza receptors [19] and
there was a 3 (62–64) amino acid deletion in the stalk of the
NA of the TS virus (Table 2). In the polymerase proteins, a
difference of 10 amino acids was observed in both the PB1 and
PB2 proteins; whereas there were 8 amino acid differences in
the PA protein (Table 3). The amino acids at positions 613 (V)
and 627 (E) in the PB2 of the TS were avian-like [25], whereas
human-like influenza signatures were found at the respective
positions (613I and 627K) in the V PB2 (Table 3). The TS
virus expresses a full-length (90 amino acids) PB1-F2 protein,
whereas the V virus expresses a truncated PB1-F2 (79 amino
acids) since there is a stop codon (amino acid position 80) in the
V PB1-F2 open reading frame. In the NP protein one human-
like signature at position 214 (K) was found in the V virus,
whereas at the same position an avian-like signature (214R) is
presented in the TS virus. There were various amino acid
differences in the M2, NS2 and the nonstructural NS1 protein
between both TS and V viruses (Table 3). Although the V
virus was isolated 4 years later than the TS virus, the
phylogenic analysis indicated that each gene segment of both
viruses belongs to the CK/BJ-like H9N2 subgroup (Data not
shown) and is not derived from other subtypes of influenza A
virus.
Amino Acid Substitution at Position 627 in PB2 Protein
Changes Virulence of the TS and V Viruses
Sequence analysis showed that there were 10 amino acid
differences in the PB2 between the TS and V viruses (Table 3); in
addition, PB2 played a major role in virus replication, tissue
tropism and pathogenicity in the studies of recombinant viruses.
To further identify the amino acid(s) in PB2 responsible for the
observed difference in viral replication and virulence of TS and V
viruses in mice, we generated eight PB2 chimeric viruses and 2
mutated viruses that contain a single substitution at the position of
627 in PB2 (Figure 3). Firstly, we generated chimera #1, #2, #3
and #4. The mouse study revealed that Chimera #2 (TS virus
possessing the N-terminal portion of the V PB2-1-344aa) and #4
(V virus possessing the C-terminal portion of the TS PB2-345-
759aa) induced less than 10% weight loss in infected mice without
mortality, whereas the chimera #1 (TS virus possessing the C-
terminal portion of the V PB2-345-759aa) and #3 (V virus
possessing the N-terminal portion of the TS PB2-1-344aa) caused
over 25% weight loss in infected mice with 100% mortality
(Figure 4A and B). Furthermore, both chimera #1 and #3
Table 2. Amino acid differences between avian influenza
H9N2 TS and V viruses Amino acid differences of surface
proteins between avian influenza H9N2 TS and V viruses.
Gene Position/H9 (H3) TS V
HA 3 (–) A V
15 (–) A V
92 (84) G R
107 (99) M L
165 (157) K E
166 (158) D N
171 (163) I V
183 (175) S N
213 (205) T A
224 (216) V L
243 (235) S A
252 (244) Q R
370 (362) V T
469 (461) M V
539 (531) M L
NA 22 F L
30 A V
62–64 – ITE
70 S G
73 I L
81 V A
83 E G
85 K R
141 K D
149 T A
153 I T
170 G A
210 M I
249 K R
296 K R
313 K D
331 N R
332 S T
356 N S
367 K E
368 E K
370 L S
380 V T
384 T I
403 W S
416 N S
432 Q K
doi:10.1371/journal.pone.0040118.t002
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chimera #2 and #4. Only chimera #3 was also detected in the
mouse brains (Figure 3). These results indicated that the last 5
amino acids at positions 378, 555, 613,627 and 649 located at C-
terminal of the PB2 are critical for viral replication and virulence
in mice.
To determine which of the 5 amino acids located at the C-
terminal of the PB2 is important for virus replication and
virulence, we generated chimera #5, #6, #7 and #8 viruses.
The results exhibited that Chimera #6 (TS virus possessing the N-
terminal portion of the V PB2-1-570aa) and #8 (V virus
possessing the C-terminal portion of the TS PB2-571-759aa) did
not induce weight loss and clinical signs in infected mice and were
similar to the controls (Figure 4A). In contrast, the chimera #5
(TS virus possessing the C-terminal portion of the V PB2-571-
759aa) and #7 (V virus possessing the N-terminal portion of the
TS PB2-1-570aa) caused obvious clinical signs and weight loss
with 100% mortality. Moreover, chimera #5 and #7 replicated to
higher virus titers in mouse lungs than the chimera #6 and #8.
However, only chimera #7 (3 and 5 dpi) and #6 (3 dpi) were also
detected in mouse brains (Figure 3). These results demonstrated
that a maximal of three amino acid positions (V613I, E627K and
V649I) at the C-terminus of the PB2 affect virulence of the TS and
V viruses in mice.
To determine the importance of amino acid at position 627 in
PB2, we generated two mutant viruses TSPB2-627K and VPB2-
627E. The mutant VPB2-627E virus encoding E at position 627 of
PB2 was not lethal and did not replicate in mouse brains when
compared to the parental r-V virus (Figure 3 and 4). However,
the mutant TSPB2-627K encoding K at position 627 of PB2 killed
all infected mice and replicated to significantly higher titers in
mouse lungs and brains when compared to the parental r-TS virus
(Figure 3 and 4). These results suggest that the amino acid at
position 627 of the PB2 is critical for differences in viral replication
and virulence between the TS and V viruses in mice.
Discussion
Several permanent lineages of H9N2 AIVs are established in
land-based poultry and have become endemic in Asia
[26,27,28,29]. Both V and TS viruses used in this study belong
to the CK/BJ-like H9N2 subgroup and are non-pathogenic in
chickens although they were isolated from diseased or dead
chickens. The diseased or dead chickens in the farms with an
outbreak of respiratory disease were most likely caused by
Table 3. Amino acid differences of internal gene proteins
between avian influenza H9N2 TS and V viruses.
Gene Amino acid position TS V
PB2 60 N D
76 T M
109 V I
188 E D
292 I V
379 R K
555 R K
613 V I
627 E K
649 V I
PB1 76 D N
111 M I
157 A T
171 T M
328 N K
368 V I
387 K Q
566 T M
621 Q K
744 T M
PA 14 V A
142 R K
185 R K
254 N T
323 V I
552 T N
683 L I
684 G E
NP 21 N D
52 H Y
214 R K
329 V I
417 S N
423 A S
473 S N
496 Y H
21 N D
M2 10 P H
16 E G
27 V I
32 V I
85 N D
NS1 26 G E
27 R L
59 H R
70 E K
86 A V
95 I L
Table 3. Cont.
Gene Amino acid position TS V
123 I T
137 T I
179 E G
180 I V
197 T N
NS2 11 G D
22 R G
40 L I
63 G W
85 H R
doi:10.1371/journal.pone.0040118.t003
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according to the IVPI test. Early H9N2 isolates from chickens
replicate poorly or not at all in mice [30]. Previous studies
showed that a few H9N2 isolates replicate systemically and are
pathogenic for mice without prior adaptation [5,18,30], indicat-
ing that some H9N2 viruses have gained the ability to cross the
species barrier and could replicate in mammalian hosts. A similar
situation is also demonstrated with the H9N2 described in this
study: the TS virus is nonlethal for mice whereas the V virus is
lethal for mice. These findings indicate that some H9N2 isolates
have expanded their host range and have adapted to mammalian
hosts. Indeed, H9N2 viruses have been isolated from pigs in
China and Korea [10,11,14,27,31] due to avian to pig
interspecies transmission; 10 genotype of H9N2 viruses were
shown to coexist in pigs in China from 1998 to 2007 [15]. More
importantly, some circulating H9N2 viruses obtained typical
human-like receptor specificity with amino acid L at position 226
at the receptor binding site [32], resulting in efficient replication
in cultured human airway epithelial cells [20]. Interestingly, most
of the recent H9N2 isolates from pigs and poultry have 226L in
HA [33], indicating that H9N2 viruses are gradually adapting to
mammals. In contrast, both the TS and V viruses contain
glutamine (Q) at position 226 in the HA, which is a typical avian-
like receptor binding marker, binding the SAa2, 3Gal receptors.
This result indicates that the HA is not the only determinant
which affects replication and pathogenicity of H9N2 AIVs in
mice. When compared to virus replication in mice, the V virus
replicated a significantly higher titer in mouse lungs than the TS
virus and it can enter the central nervous system with a detectable
titer. The recombinant viruses such as V-TSPA, -HA, -NA and -
NS replicated comparable titers in mouse lungs as the V virus
did, but they were not detected from mouse brains. They caused
less mortality in mice when compared to the V virus, indicating
that replication in brain might enhance viral virulence in mice
although virus replication in lungs seems to be the major
determinant for the mouse mortality to the infection.
H9N2 viruses have infected humans, leading to mild respira-
tory disease in people from Hongkong and mainland China
during 1999–2003 [12,16,17]. The infection of humans with
H9N2 viruses resulted in typical human flu-like illness that can be
easily associated with seasonal flu viruses and overlooked. H9N2
viruses could have the potential to become a human pandemic
strain in addition to the highly pathogenic H5N1 virus, which is
considered to be a major pandemic threat [34]; H5N1 viruses
cause infection with high mortality in humans and spread from
Asia into Africa and Europe due to its association with wild
migratory birds [35,36]. To date, the mechanism of adaptation
and interspecies transmission of H9N2 viruses from birds to
mammals remains poorly understood. Our present study using
two H9N2 field chicken isolates showed the adaptation and
pathogenicity of H9N2 influenza viruses in mice is largely
attributed to the PB2 gene. Previous studies have shown that PB2
627K in human influenza viruses and highly pathogenic H5N1
AIVs plays an important role in the host range and replication in
mammalian hosts [22,23,37]. Adaptation of H9N2 virus to quail
and chickens facilitates this strain with expanded host range, i.e.,
it was shown that an H9N2 virus replicates more efficiently in
mice and the mouse-adapted virus has the mammalian signature
627K in PB2 after adaptation to land- based poultry [3]. A
serially passaged chicken H9N2 virus in mouse lungs also
contains PB2 627K [24]. All these results suggest that PB2
627K is very important for virulence and mouse-adaptation of
the H9N2 virus. To our knowledge, to date only one H9N2 field
strain was found to have PB2 627K prior to this study, which was
isolated from the ostrich in South Africa (A/ostrich/South
Africa/9508103/95, GenBank accession No. AF508640). Herein,
we showed that a chicken field H9N2 isolate already contains
PB2 627K that is crucial for pathogencity and tissue tropism in
mice. This finding suggests that H9N2 viruses started to adapt to
the mammalian hosts not only on the HA but also the PB2 gene.
Surprisingly, the H9N2 virus with PB2 627K is first isolated from
poultry rather than from the mammalian hosts such as swine or
humans. This scenario is somehow different with the H5N1 virus
Figure 3. Schematic diagram of chimeric and single amino acid PB2 mutants and virus titers in mouse lungs and brains. Differences
of amino acid residues in PB2 between TS and V virus were shown as single-letter amino acid codes with their positions indicated at the top of the
diagram. The red and blue bars indicate the amino acid regions originated from TS or V, respectively. Virus titers are presented by log10 geometric
mean EID50/ml 6 SEM (The detection limit is 10
1 EID50/ml).
doi:10.1371/journal.pone.0040118.g003
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and other mammalian species such as tigers [39], dogs [40] and
cats [41]. Whether the H9N2 virus will enhance replication and
virulence in humans and swine with the acquisition of PB2 627K
needs to be investigated.
All chimeric V viruses containing V PB2 C-terminal with
627K are able to replicate in mouse brains. In the TS
background, V PB2 C-terminal 627K chimeric viruses did not
replicate in mouse brains although the recombinant virus TS-
VPB2 does, indicating that other amino acids except 627K also
play a role in viral replication in mouse brains. The chimera
#6 (TS virus possessing the N-terminal portion of the V PB2-
570aa) replicated in mouse brains on 3 dpi, whereas the
chimera #2 (TS virus possessing the N-terminal portion of
the V PB2-344aa) did not. This result indicates that amino acids
379K and 555K are critical for replication of TS chimeric
viruses in mouse brains since there are only 2 amino acid
differences between chimera #2 and #6.
Besides PB2, other genes are also associated with pathogenicity
of influenza A virus. Several genes from the TS virus attenuated
the V virus, especially the PB1, NP or M genes. All of these
recombinant viruses caused less mortality although they still
caused disease in mice, indicating that these genes are important
for the virulence of the V virus. Vice versa, the PA or NA gene
from the V virus enhanced pathogenicity of the TS virus when
compared to the parental r-TS virus. Furthermore, the NP gene
affected viral replication in mouse lungs in both TS and V genetic
background although not as prominent as the PB2 did. All these
Figure 4. Weight changes and mortality of mice inoculated with parental, chimeric or mutated viruses. A) Weight changes; B) Mortality
of mice inoculated with parental, chimeric or mutated viruses.
doi:10.1371/journal.pone.0040118.g004
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polygenic trait. Which domain or amino acid (s) within the above
described genes contributes to pathogenicity in mice needs to be
investigated in future studies.
The polymerase subunit PB1, PB2, PA along with NP and viral
RNA form the ribonucleoprotein which is responsible for viral
replication and transcription. Numerous studies have shown that
the amino acid at position 627 in PB2 affects polymerase activity
and replication efficiency [42]. Our findings support this
conclusion since the H9N2 virus with PB2 627K produced higher
virus titers in lungs when compared to the virus with PB2 627E in
mice. However, other residues of the PB2 also seem to have
impact on viral replication and tissue tropism of H9N2 viruses in
mice; how and which specific residues of the PB2 need to be
determined in future studies.
Taken together, we showed a mammalian adapted signature
PB2 627K in an H9N2 field isolate and demonstrated that PB2
627K plays an important role for the virulence and tissue tropism
of H9N2 AIVs in mice. This study supports the previous finding
that PB2 627K is an important determinant of host range and
virulence of influenza A viruses.
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